Skip to content

A prospective observational study to examine the role of individual natriuretic peptides forms for left ventricular remodeling in patients with acute myocardial infarction

A prospective observational study to examine the role of individual natriuretic peptides forms for left ventricular remodeling in patients with acute myocardial infarction - A prospective observational study to examine the role of individual natriuretic peptides forms for left ventricular remodeling in patients with acute myocardial infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000054727
Enrollment
170
Registered
2024-07-01
Start date
2012-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

None listed

Sponsors

National Cerebral and Cardiovascular Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) onset-to-reperfusion time within 24 hours, (2) first episode of acute myocardial infarction, (3) Killip Class 1-2, (4) serum creatinine levels below 1.5 mg/dl, and (6) hemoglobin levels of 11 g/dl or more

Exclusion criteria

Exclusion criteria: (1) no reperfusion or final thrombolysis in myocardial infarction grade of 0 or 1, (2) presence of multiple organ failure, (3) occurrence of mechanical complications of AMI or refractory cardiogenic shock, (4) undergoing emergent or urgent CABG as a reperfusion therapy, (5) history of any malignancy, (6) experiencing difficulty in self-judgment due to neurological disease, mental illness, or dementia.

Design outcomes

Primary

MeasureTime frame
Change in left ventricular volume and ejection fraction from 1 year to acute phase after index acute myocardial infarction

Secondary

MeasureTime frame
major adverse cardiac and cerebrovascular events composed of all-cause death, stroke, acute coronary syndrome (ACS), hospitalization for heart failure, fatal ventricular arrhythmias, and stroke

Countries

Japan

Contacts

Public ContactYasuhide Asaumi

National Cerebral and Cardiovascular Center Department of Cardiovascular Medicine

asaumiya@ncvc.go.jp+81-6-6170-1070

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026